(Q43699921)

26 November 2017

title

Combined aberrant expression of microRNA-214 and UBC9 is an independent unfavorable prognostic factor for patients with gliomas (English)

1 reference

26 November 2017

1 reference

Shuai Wang

1

1 reference

26 November 2017

Baohua Jiao

2

1 reference

26 November 2017

Shaomei Geng

3

1 reference

26 November 2017

Shucheng Ma

4

1 reference

26 November 2017

Zhaohui Liang

5

1 reference

26 November 2017

Shengkui Lu

6

1 reference

26 November 2017

language of work or name

1 reference

26 November 2013

1 reference

26 November 2017

1 reference

26 November 2017

volume

31

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

767

1 reference

Current epidemiological trends and surveillance issues in brain tumors

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Predictive and prognostic factors for gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

The 2007 WHO classification of tumors of the central nervous system - what has changed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

State-of-the-art treatment of high-grade brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Epidemiology and etiology of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

New microRNAs from mouse and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Non-coding RNAs in cancer initiation and progression and as novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

MicroRNA trafficking and human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Tumor microRNA-335 expression is associated with poor prognosis in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Resveratrol repressed viability of U251 cells by miR-21 inhibiting of NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

microRNA-214-mediated UBC9 expression in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Ubc9 is a novel modulator of the induction properties of glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer cell proliferation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0767-5

MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression

21 January 2018

1 reference

12 December 2020

microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma

1 reference

12 December 2020

Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues

1 reference

12 December 2020

MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells

1 reference

12 December 2020

10.1007/S12032-013-0767-5

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

1034924781

0 references

1 reference